Karl Härfstrand
Founder at Härfstrand Consulting AG
Net worth: - $ as of 2024-04-29
Karl Härfstrand active positions
| Companies | Position | Start | End |
|---|---|---|---|
Härfstrand Consulting AG
 Härfstrand Consulting AG Miscellaneous Commercial ServicesCommercial Services Härfstrand Consulting AG provides management consulting services. The private company is based in Zug, Switzerland. The Swiss company was founded by Karl Anders Olof Härfstrand. | Chairman | 2010-07-31 | - |
| Founder | 2010-07-31 | - |
Career history of Karl Härfstrand
Former positions of Karl Härfstrand
| Companies | Position | Start | End |
|---|---|---|---|
| PROTHENA CORPORATION PLC | Director/Board Member | 2015-06-28 | 2024-05-13 |
| Independent Dir/Board Member | 2015-06-28 | 2024-05-13 | |
| BRAIN+ A/S | Chairman | 2022-09-01 | 2024-01-30 |
| VIVESTO AB | Director/Board Member | 2019-09-25 | 2020-04-30 |
| Chairman | 2020-04-30 | 2022-05-24 | |
| Independent Dir/Board Member | 2019-09-25 | 2022-05-24 | |
| DIUL GROUP | Chairman | 2021-11-14 | 2021-12-31 |
| KAROLINSKA DEVELOPMENT AB | Director/Board Member | 2017-05-23 | 2018-12-31 |
| Independent Dir/Board Member | 2017-05-23 | 2018-12-31 | |
to-BBB technologies BV
 to-BBB technologies BV Pharmaceuticals: MajorHealth Technology BBB Therapeutics BV develops medicines for brain disease treatment. The firm uses its platform technology to enhance the delivery of established and marketed drugs over the blood brain-barrier. It offers its patented central nervous system (CNS) drug targeting technology to their partners in pharmaceutical and biotechnology industry. The firm's products include 2B3-101 and 2B3-201. The company was founded by Pieter Jaap Gaillard, Bert de Boer, and Alfred N. Nijkerk in 2003 and is headquartered in Leiden, the Netherlands. | Chief Executive Officer | 2014-09-08 | 2014-12-31 |
to-BBB Holding BV
 to-BBB Holding BV Pharmaceuticals: GenericHealth Technology to-BBB Holding BV operated as a holding company with interest in providing central nervous system drug technology to the pharmaceutical and biotechnology industries. The firm developed medicines for the treatment of brain diseases. The company was headquartered in The Hague, the Netherlands. | Chief Executive Officer | 2014-09-08 | 2014-12-31 |
| ADAMA AGRICULTURAL SOLUTIONS LTD | Corporate Officer/Principal | 2012-12-31 | 2013-12-31 |
| ░░░░░ ░░░░░░░░░░░ ░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
| ░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
| ░░░░░ ░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░ ░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
| ░░░░░░░ ░░░░░░░░░░░░ ░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
| ░░░░░░ ░░░░░░░░░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░ ░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
| ░░░░░░░░░ ░ ░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
| ░░░░ ░░░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
| ░░░░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
Training of Karl Härfstrand
| Karolinska Institutet | Doctorate Degree |
Statistics
International
| Switzerland | 7 |
| Sweden | 6 |
| United States | 5 |
Operational
| Director/Board Member | 9 |
| Corporate Officer/Principal | 7 |
| Chief Executive Officer | 5 |
Sectoral
| Health Technology | 13 |
| Commercial Services | 4 |
| Process Industries | 4 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 4 |
|---|---|
| PROTHENA CORPORATION PLC | Health Technology |
| KAROLINSKA DEVELOPMENT AB | Finance |
| VIVESTO AB | Health Technology |
| BRAIN+ A/S | Technology Services |
| Private companies | 18 |
|---|---|
Acino International AG
 Acino International AG Pharmaceuticals: MajorHealth Technology Acino International AG develops and manufactures pharmaceuticals in novel drug delivery form. The firm provides drug delivery technologies with a focus on modified release oral forms, oral dispersible forms, transdermal systems and extended release parenterals, for which it also holds patents. It offers abelcet, bactiflox, clopacin, dolonica, hydronica, neurorubine, olfen and spasfon. The company was founded in 1836 and is headquartered in Zurich, Switzerland. | Health Technology |
Pfizer Japan, Inc.
 Pfizer Japan, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Pfizer Inc., Pfizer Japan, Inc. is a research and Japanese development pharmaceutical company founded in 1953. The company is based in Tokyo, Japan. The company's focus is on breakthroughs that greatly change patients' lives, contributing to the improvement of patients' health and life expectancy. | Commercial Services |
OphthalmoPharma AG
 OphthalmoPharma AG Medical SpecialtiesHealth Technology OphthalmoPharma AG develops ophthalmology treatments. Its product pipeline addresses major unmet medical needs including dry eye syndrome, glaucoma, and age-related macular degeneration. The company's product include EyeBar, a nutraceutical for the prevention of dry age-related macular degeneration and the preloaded injector for delivery of intraocular lens in cataract and corrective lens replacement surgery. OphthalmoPharma was founded by Sebastien Putallaz and Gamil G. de Chadarevian in 2003 and is headquartered in Sarnen, Switzerland. | Health Technology |
HeiQ Materials AG
 HeiQ Materials AG TextilesProcess Industries HeiQ Materials AG develops and manufactures antimicrobial silver and other sustainable textile effects. It offers textile brands innovation research and development, customized chemical manufacturing, and ingredient branding in one. The company was founded by Carlo Centonze and Murray Height in 2005 and is headquartered in Schlieren, Switzerland. | Process Industries |
Horizon Therapeutics Switzerland GmbH
 Horizon Therapeutics Switzerland GmbH Pharmaceuticals: MajorHealth Technology Horizon Therapeutics Schweiz GmbH is a biopharmaceutical company that develops and commercializes medicines to target unmet therapeutic needs in arthritis, pain and inflammatory diseases. The company was originally founded in 2004 as a spin-out of Merck KGaA and is headquartered in Reinach, Switzerland. | Health Technology |
| Serono International SA | |
| Pharmacia, Inc. | |
| Pharmacia AB | Health Technology |
| Pharmacia & Upjohn, Inc. | Health Technology |
ADAMA Agriculture BV
 ADAMA Agriculture BV Chemicals: AgriculturalProcess Industries ADAMA Agriculture BV is a Dutch company that manufactures biocidal products for crop protection. The private company is based in Leusden, NL. and has subsidiaries in Italy, Romania, Czechia and United Kingdom. | Process Industries |
Ascenditur AB
 Ascenditur AB Medical SpecialtiesHealth Technology Ascenditur AB engages in the manufacturing of irradiation, electro medical, and electrotherapeutic equipment. It offers products, methods, and know-how within light therapy technology for performance during exercises and recovery. The company was founded in 2007 and is headquartered in Stockholm, Sweden. | Health Technology |
to-BBB Holding BV
to-BBB Holding BV Pharmaceuticals: GenericHealth Technology to-BBB Holding BV operated as a holding company with interest in providing central nervous system drug technology to the pharmaceutical and biotechnology industries. The firm developed medicines for the treatment of brain diseases. The company was headquartered in The Hague, the Netherlands. | Health Technology |
to-BBB technologies BV
to-BBB technologies BV Pharmaceuticals: MajorHealth Technology BBB Therapeutics BV develops medicines for brain disease treatment. The firm uses its platform technology to enhance the delivery of established and marketed drugs over the blood brain-barrier. It offers its patented central nervous system (CNS) drug targeting technology to their partners in pharmaceutical and biotechnology industry. The firm's products include 2B3-101 and 2B3-201. The company was founded by Pieter Jaap Gaillard, Bert de Boer, and Alfred N. Nijkerk in 2003 and is headquartered in Leiden, the Netherlands. | Health Technology |
Humabs BioMed SA
 Humabs BioMed SA Miscellaneous Commercial ServicesCommercial Services Humabs BioMed SA is an antibody therapeutics biotechnology company. It develops human monoclonal antibody platforms for treatment of infectious and inflammatory diseases. The company was founded by Prof. Antonio Lanzavecchia on October 24, 2011 and is headquartered in Bellinzona, Switzerland. | Commercial Services |
Härfstrand Consulting AG
Härfstrand Consulting AG Miscellaneous Commercial ServicesCommercial Services Härfstrand Consulting AG provides management consulting services. The private company is based in Zug, Switzerland. The Swiss company was founded by Karl Anders Olof Härfstrand. | Commercial Services |
ADAMA Agricultural Solutions Ltd.
 ADAMA Agricultural Solutions Ltd. Chemicals: AgriculturalProcess Industries ADAMA Agricultural Solutions Ltd. engages in the development, manufacture, and sale of crop and non-crop protection products. Its products and services include weed control, pest control, disease control, crop enhancers, and seed treatment. The company was founded in December 1997 and is headquartered in Tel Aviv, Israel. | Process Industries |
EMD Serono, Inc.
 EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Health Technology |
Diurnal Group Ltd.
 Diurnal Group Ltd. Pharmaceuticals: MajorHealth Technology Diurnal Group plc engages in the development of products for the life-long treatment of chronic endocrine conditions, including congenital adrenal hyperplasia and adrenal insufficiency. It focuses on circadian-based endocrinology to yield novel product candidates in the rare and chronic endocrine disease arena. The company was founded by Richard John Martin Ross in 2004 and is headquartered in Cardiff, the United Kingdom. | Health Technology |
- Stock Market
- Insiders
- Karl Härfstrand
- Experience